✦ LIBER ✦

Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations

✍ Scribed by A. MacGowan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Animal reservoirs for extended spectrum

✍ A. Carattoli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Treatment options for extended-spectrum

✍ Sabiha Y Essack 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Treatment options for extended-spectrum

✍ Sabiha Y Essack 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

430 Extended Spectrum β-Lactamase (ESBL)

✍ K.T. Bui; C.L. Maree; B.M. Kubak; M. Carlson; R.J. Landovitz; D.J. Ross; D.A. Pe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Pharmacodynamics of intermittent and con

✍ Alicia M. Reese; Christopher R. Frei; David S. Burgess 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Impact of changes in CLSI and EUCAST bre

✍ J. Rodríguez-Baño; E. Picón; M. D. Navarro; L. López-Cerero; Á. Pascual; the ESB 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB